Investigación > Enfermedades crónicas, Cirugía y Cuidado de la Salud

Grupo de Investigación en Inmunología y Metabolismo (GRIM)

Número de publicaciones
348
Buscador de publicaciones
  • Lopez-Cano, C; Lecube, A; Garcia-Ramirez, M; Muñoz X; Sanchez, E; Seminario, A; Hernandez, M; Ciudin, A; Gutierrez, L; Hernandez, C; Simo, R

    Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 102 4109-4116. .

    [doi:10.1210/jc.2017-00913]

  • Granado-Casas, M; Martinez-Alonso, M; Alcubierre, N; Ramirez-Morros, A; Hernandez, M; Castelblanco, E; Torres-Puiggros, J; Mauricio, D

    Decreased quality of life and treatment satisfaction in patients with latent autoimmune diabetes of the adult

    PeerJ 5 -. .

    [doi:10.7717/peerj.3928]

  • Gomez-Peralta, F; Abreu, C; Lecube, A; Bellido, D; Soto, A; Morales, C; Brito-Sanfiel, M; Umpierrez, G

    Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

    Diabetes Therapy 8 953-962. .

    [doi:10.1007/s13300-017-0277-0]

  • Gomez-Peralta, F; Abreu, C; Lecube, A; Bellido, D; Soto, A; Morales, C; Brito-Sanfiel, M; Umpierrez, G

    Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes (vol 8, pg 953, 2017)

    Diabetes Therapy 8 963-965. .

    [doi:10.1007/s13300-017-0290-3]

  • Lecube, A.; Sanchez, E.; Betriu, A.; Gutierrez-Carrasquilla, L.; Elias, M.; Barbe, F.; Purroy, F.; Buti, M.; Fernandez, E.; Lopez-Cano, C.

    Impaired pulmonary function in type 2 diabetes: Is there a role for advanced glycation end-products measured by skin autofluorescence?Data form the ILERVAS project

    Diabetologia 60 503-503. .

  • Pardina, E; Ferrer, R; Rossell, J; Ricart-Jane, D; Mendez-Lara, KA; Baena-Fustegueras, JA; Lecube, A; Julve, J; Peinado-Onsurbe, J

    Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery

    INTERNATIONAL JOURNAL OF OBESITY 41 1388-1393. .

    [doi:10.1038/ijo.2017.115]

  • Lara, B; Canas, F; Vidal, A; Nadal, N; Rius, F; Paredes, E; Hernandez, M; Maravall, FJ; Franch-Nadal, J; Barbe, F; Mauricio, D

    Knowledge management through two virtual communities of practice (Endobloc and Pneumobloc)

    HEALTH INFORMATICS JOURNAL 23 170-180. .

    [doi:10.1177/1460458216639739]

  • Castelblanco, E.; Hernandez, M.; Castelblanco, A.; Esquerda, A.; Mollo, A.; Ramirez-Morros, A.; Franch-Nadal, J.; Fernandez-Real, J. M.; Mauricio, D.

    Low-grade inflammatory marker profile is mainly driven by adiposity-related characteristics in patients with LADA, type 1 and type 2 diabetes

    Diabetologia 60 200-200. .

  • Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X

    A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium

    CELL DEATH AND DIFFERENTIATION 24 1443-1458. .

    [doi:10.1038/cdd.2017.73]

  • Hernandez, M; Lopez, C; Real, J; Valls, J; Ortega-Martinez de Victoria E; Vazquez, F; Rubinat, E; Granado-Casas, M; Alonso, N; Moli, T; Betriu, A; Lecube, A; Fernandez, E; Leslie, RD; Mauricio, D

    Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes

    Cardiovascular Diabetology 16 94-94. .

    [doi:10.1186/s12933-017-0576-9]

  • Perez-Segura, P; Palacio, JE; Vazquez, L; Monereo, S; de Las Peñas R; de Icaya, PM; Gravalos, C; Lecube, A; Blasco, A; Garcia-Almeida, JM; Barneto, I; Goday, A

    Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology

    CLINICAL & TRANSLATIONAL ONCOLOGY 19 682-694. .

    [doi:10.1007/s12094-016-1601-2]

  • Mizab Mellah, Chadia; Sanchez Perez, Marta; Santos Rey, Maria Dolores; Hernandez Garcia, Marta

    Fulminant type 1 diabetes mellitus associated with pembrolizumab

    ENDOCRINOLOGIA DIABETES Y NUTRICION 64 272-273. .

    [doi:10.1016/j.endinu.2017.01.005]